Epicardio signed a collaboration and reseller agreement with CHART Healthcare Academy in the USA
Epicardio Simulation™ is celebrating more than 6,000 individual users from around the world in 2022. A total of 72,324 hours were spent on Epicardio apps, with more that 18 hours of total average daily usage. Overall Epicardio usage more than doubled since 2021.
Epicardio wins prestigious Global Cooperation grant award by Innovate UK, aiming to facilitate Epicardio’s entry into the North American medical education market. As part of this project we will start trials at leading medical schools in USA, Canada and Mexico.
Epicardio releases two CPD certified apps on the App Store and Google Play
“Temporary Cardiac Pacing” and “Atrial Fibrillation”
Epicardio participated in CANeLearn Leadership Summit 2021
as part of the Global Business Innovation Programme – Canada & USA EdTech hosted by Innovate UK
Dr Vassilios Hurmusiadis presenting Epicardio Simulation™ at Arrhythmias Update 2021 in Thessaloniki, Greece
Epicardio is participating in the ASU + GSV Summit 2021, under the Global Business Innovation #edtech programme hosted by Innovate UK Edge
Epicardio participating in the Global Business Innovation Programme – GBIP 2021, focused on Canada & USA #EdTech market
Programme funded by Innovate UK and UK Research and Innovation
